As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

Pharmacy Benefit Managers (PBM) sit in the center of our prescription drug system, coordinating between insurance companies, ...

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Mintz’s Health Law and Antitrust teams actively monitor federal and state regulatory and legislative developments in the PBM ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...

The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...